Jerome Windsor - Median Technologies Insider

ALMDT -- France Stock  

EUR 6.40  0.06  0.93%

Vice President - Business Development Pharma
Mr. Jerome Windsor has served as Vice President Business Development Pharma at Median Technologies SA. He was former Vice President of commercial development and Strategic Partners of i3, UnitedHealth group subsidiary dedicated to Clinical Research and has over 16 years experience in pharmaceutical, biotech and CRO industries. He previously was European Development Manager at Covance, Cerep, and Consultant at Pricewaterhousecoopers and Accenture
33 4 93 33 37 77
Windsor is cofounder of ANS Biotech, a research company specialized in pain pharmacology. He is Pharm.D. and holds a MBA from ESSEC French Business School.

Management Efficiency

The company has return on total asset (ROA) of (26.46) % which means that it has lost $26.46 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (54.04) % meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 4 K in total debt. Median Technologies SA has Current Ratio of 4.43 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.

Similar Executives

Entity Summary

Median Technologies SA operates in the field of medical imaging in France and internationally. Median Technologies SA was founded in 2002 and is headquartered in Valbonne, France. Median Technologies operates under Diagnostics Research classification in France and traded on Paris Stock Exchange. It employs 114 people.Median Technologies SA (ALMDT) is traded on Paris Stock Exchange in France. It is located in Les Deux Arcs and employs 114 people.

Median Technologies SA Leadership Team

Fredrik Brag, Chairman
Gerard Milhiet, Director
Michael Auffret, VP
Jacques Souquet, Director, Ph.D
Franck Lescure, Director, MBA
Arnaud Butzbach, Founder
Oran Muduroglu, Director
Jeanne Hecht, COO, MBA
Nicholas Campbell, Executive, MBA
Jerome Windsor, President, MBA
Souhil Zaim, Director
Takashi Mori, Director, MBA
Dennis Atkinson, Director
Bernard Reymann, CFO

Stock Performance Indicators

Current Sentiment - ALMDT

Median Technologies SA Investor Sentiment
Macroaxis portfolio users are unresponsive in their sentiment towards investing in Median Technologies SA. What is your trading attitude regarding investing in Median Technologies SA? Are you bullish or bearish?
50% Bullish
50% Bearish

Pair Correlation

Equities Pair Trading Analysis
Correlation analysis and pair trading evaluation for Median Technologies and Amplitude Surgical SA. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check also Trending Equities. Please also try Portfolio Reporting module to create custom reports across your portfolios and generate quick suggestion pitch.